{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,3,7]],"date-time":"2024-03-07T06:05:00Z","timestamp":1709791500163},"reference-count":10,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gastroenterolog\u00eda y Hepatolog\u00eda"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1016\/j.gastrohep.2013.06.008","type":"journal-article","created":{"date-parts":[[2013,9,9]],"date-time":"2013-09-09T20:26:09Z","timestamp":1378758369000},"page":"21-22","source":"Crossref","is-referenced-by-count":2,"title":["Infliximab en el tratamiento de la enfermedad de Crohn gastroduodenal resistente"],"prefix":"10.1016","volume":"37","author":[{"given":"Mar\u00eda del Carmen","family":"Rodr\u00edguez-Grau","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda","family":"Chaparro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raquel","family":"D\u00edaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier P.","family":"Gisbert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.gastrohep.2013.06.008_bib0005","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/00054725-200105000-00004","article-title":"Impact of different therapeutic regimens on the outcome of patients with Crohn's disease of the upper gastrointestinal tract","volume":"7","author":"Miehsler","year":"2001","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.gastrohep.2013.06.008_bib0010","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/00054725-200303000-00008","article-title":"Gastroduodenal Crohn's disease: Medical management","volume":"9","author":"Tremaine","year":"2003","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.gastrohep.2013.06.008_bib0015","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1002\/ibd.20103","article-title":"Esophageal Crohn's disease treated successfully with adalimumab","volume":"13","author":"Kwan","year":"2007","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.gastrohep.2013.06.008_bib0020","first-page":"197","article-title":"Infliximab treatment of massive upper gastrointestinal bleeding in gastroduodenal Crohn's disease","volume":"19","author":"Kocaman","year":"2008","journal-title":"Turk J Gastroenterol"},{"key":"10.1016\/j.gastrohep.2013.06.008_bib0025","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1097\/00054725-200111000-00010","article-title":"Proximal Crohn's disease: Review of the clinicopathologic features and therapy","volume":"7","author":"van Hogezand","year":"2001","journal-title":"Inflamm Bow Dis"},{"key":"10.1016\/j.gastrohep.2013.06.008_bib0030","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1542\/peds.83.5.777","article-title":"High incidence of upper gastrointestinal tract involvement in children with Crohn disease","volume":"83","author":"Lenaerts","year":"1989","journal-title":"Pediatrics"},{"key":"10.1016\/j.gastrohep.2013.06.008_bib0035","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.crohns.2009.12.002","article-title":"The second European evidence-based consensus on the diagnosis and management of Crohn's disease: Current management","volume":"4","author":"Dignass","year":"2010","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.gastrohep.2013.06.008_bib0040","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/S0140-6736(02)08512-4","article-title":"Maintenance infliximab for Crohn's disease: The ACCENT I randomized trial","volume":"359","author":"Hanauer","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.gastrohep.2013.06.008_bib0045","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1007\/s10620-012-2072-0","article-title":"Upper gastrointestinal involvement of Crohn's disease: A prospective study on the role of upper endoscopy in the diagnostic work-up","volume":"57","author":"Annunziata","year":"2012","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.gastrohep.2013.06.008_bib0050","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1002\/ibd.22902","article-title":"Doubling the infliximab dose versus halving the infusion intervals in Crohn's disease patients with loss of response","volume":"18","author":"Katz","year":"2012","journal-title":"Inflamm Bowel Dis"}],"container-title":["Gastroenterolog\u00eda y Hepatolog\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0210570513001921?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0210570513001921?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,3,5]],"date-time":"2022-03-05T21:49:27Z","timestamp":1646516967000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0210570513001921"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":10,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["S0210570513001921"],"URL":"https:\/\/doi.org\/10.1016\/j.gastrohep.2013.06.008","relation":{},"ISSN":["0210-5705"],"issn-type":[{"value":"0210-5705","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]}}}